Will a nasal corticosteroid improve control for patients with step 3 or higher persistent asthma? - 05/03/15
Doi : 10.1016/j.jaci.2014.12.1910
Paul A. Greenberger, MD ⁎ 
Division of Allergy-Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill
∗Corresponding author: Paul A. Greenberger, MD, 676 N Clair St, #14018, Chicago, IL 60611.
Key words : United, unified, nasal, corticosteroid, rhinosinusitis, asthma, control
Le texte complet de cet article est disponible en PDF.
| Supported by the Ernest S. Bazley Grant to Northwestern University and Northwestern Memorial Hospital. |
|
| Disclosure of potential conflict of interest: P. A. Greenberger has received consultancy fees from Mylan and receives royalties from Wolters Kluwer Lippincott and Williams & Wilkins. |
© 2015
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 135 - N° 3
P. 710-711 - mars 2015 Retour au numéro
Article précédent
- Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma
- American Lung Association–Asthma Clinical Research Centers' Writing Committee:, Anne E. Dixon, Mario Castro, Rubin I. Cohen, Lynn B. Gerald, Janet T. Holbrook, Charles G. Irvin, Shyam Mohapatra, Stephen P. Peters, Sobharani Rayapudi, Elizabeth A. Sugar, Robert A. Wise
- Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin
- Joel Correa da Rosa, Dana Malajian, Avner Shemer, Mariya Rozenblit, Nikhil Dhingra, Tali Czarnowicki, Saakshi Khattri, Benjamin Ungar, Robert Finney, Hui Xu, Xiuzhong Zheng, Yeriel D. Estrada, Xiangyu Peng, Mayte Suárez-Fariñas, James G. Krueger, Emma Guttman-Yassky
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?